SCHEMBL29397543

SCHEMBL29397543

FC(F)(F)c1cnc2cc(Br)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 1/20 0.54
▸ PABPC1 P11940 1/20 0.41
▸ HDAC4 P56524 2/20 0.40
▸ PTGES O14684 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ THRB P10828 1/20 0.37
▸ PIK3CA P42336 2/20 0.36
▸ PIK3R1 P27986 1/20 0.36
▸ BACE1 P56817 2/20 0.35
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HCAR1 Q9BXC0 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PI4KA P42356 1/20 0.33
▸ PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16112819 1.00 NT5E (0.54) NT5EPABPC1HDAC4PTGESKDM4E
SCHEMBL30134165 0.93 NT5E (0.54) NT5EPABPC1HDAC4PTGESKDM4E
SCHEMBL20364201 0.93 NT5E (0.54) NT5EPABPC1HDAC4PTGESKDM4E
SCHEMBL13208485 0.82 PABPC1 (0.41) NT5EPABPC1PTGESHTTCYP1A2
SCHEMBL30134297 0.79 NT5E (0.44) NT5EPABPC1HDAC4PTGESHTT
SCHEMBL14242807 0.79 ESR2 (0.42) NT5EHDAC4KDM4EHTTMAPT
SCHEMBL20364204 0.79 TLR9 (0.50) NT5EHDAC4KDM4EHTTPIK3CA
SCHEMBL13347723 0.79 NQO2 (0.46) HDAC4KDM4EHTTCYP1A2LMNA
SCHEMBL30702108 0.79 TLR9 (0.50) NT5EHDAC4KDM4EHTTPIK3CA
Hydrochloric Acid SCHEMBL28217861 0.77 TLR9 (0.49) NT5EHDAC4KDM4EHTTPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114144413-A PARP1 inhibitors 阿斯利康(瑞典)有限公司 2022-03-04 — — CN disclosed
Send feedback